Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up

Abstract

We have externally validated two prediction tools for IgA nephropathy. The International IgAN Prediction Tool performed well, while the IgA Nephropathy Clinical Decision Support System has some limitations.